McNeill Lori - Insider Non-Derivative Transactions at Sonnet BioTherapeutics Holdings, Inc. (SONN) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 2, 2025, McNeill Lori's relationship to Sonnet BioTherapeutics Holdings, Inc. (SONN) is Director, and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SONN insiders.

Related Topics: SEC Topic List.
Data Source: SEC.
McNeill Lori - Insider Non-Derivative Transactions of SONN Common Stock
McNeill Lori - Insider Non-Derivative Transactions at SONN
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Dec 3, 2025 Disposition -- (Common Stock) 4394 0 0
Jul 12, 2025 Acquisition -- (Common Stock) 4000 0 4394
Dec 12, 2023 Acquisition -- (Common Stock) 373 0 394